Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
P&G falls after missing Q2 net sales estimates
Shares of consumer goods bellwether Procter & Gamble PG.N fall 1.4% to $144.04 premarketCo's Q2 net sales at $22.21 billion, falling just short of analysts' estimates of $22.28 billion - LSEG dataCo posts quarterly EPS of $1.88 vs. estimates of $1.86Co's core gross margin falls for t...
Reuters
Thu, Jan 22
MIDEAST STOCKS-Major Gulf markets track global shares higher
By Ateeq Shariff Jan 22 (Reuters) - Most stock markets in the Gulf closed higher on Thursday, in line with global shares, after U.S. President Donald Trump backed away from imposing tariffs on eight European countries, lifting global investor sentiment.Trump's tariff threats, floated as lever...
Reuters
Thu, Jan 22
Sweetgreen: Can This Salad Chain Grow Into a Long-Term Compounder?
Key PointsSweetgreen's focus on automation makes it an innovative competitor in the restaurant sector. Consumers are pulling back, impacting the company’s foot traffic and same-store sales. Sweetgreen must show meaningful fundamental improvements before it can drive investor optimism. 10 stocks we ...
The Motley Fool
Thu, Jan 22
Medicus Pharma gains after cutting royalty payment to Teverelix
Shares of drug developer Medicus Pharma MDCX.O rise 12% to $1.49 premarket Co says it has cut royalty payments on investigational prostate cancer drug teverelix to 2% from ~4% after amending its deal with UK research group LifeArcCo's teverelix is being tested for advanced prostate cancer and re...
Reuters
Thu, Jan 22
Is It Too Late to Buy Navitas Semiconductor After Its Big Run?
Navitas Semiconductor (NASDAQ: NVTS) is shifting away from low-margin consumer chips and betting big on AI data centers. If NVIDIA's 800V transition plays out, this volatile stock could surprise investors.Stock prices used were the market prices of Jan. 19, 2026. The video was published on Jan. 21, ...
The Motley Fool
Thu, Jan 22
WhiteFiber slides after increased $210 mln convertible bond offering
Shares of AI infrastructure firm WhiteFiber WYFI.O down 5.2% to $19.26 before the bell after slightly upsized raiseWYFI announces pricing private offering of $210 mln 4.5% 5-yr convertible bonds (CBs)Offering size increased from $200 mln; initial conversion price set at $25.91, 27.5% above stock...
Reuters
Thu, Jan 22
Huntington forecasts record interest income in 2026 as margins expand, loans grow
Jan 22 (Reuters) - Huntington Bancshares HBAN.O said on Thursday it expects its interest income for 2026 to hit a record high, as the regional lender benefits from accelerating loan demand and expanding margins.Borrowing has picked up across the banking industry, supported by interest rate cuts by t...
Reuters
Thu, Jan 22
All Medicare Advantage Enrollees Should Do This By March 31
Key PointsMedicare Advantage has its own special open enrollment period.If you're on a Medicare Advantage plan now, you can make changes to your coverage between now and Mar. 31.It's important to take advantage of that option if your current plan is costing you more than expected or you don't have a...
The Motley Fool
Thu, Jan 22
Street View: Analysts see upside for Kinder Morgan as natural gas demand fuels project growth
Kinder Morgan KMI beat fourth-quarter profit estimates on Wednesday, and it remains bullish on long-term natural gas demandPosts Q4 adjusted profit of 39 cents per share compared with analysts' estimate of 37 cents per share - data compiled by LSEG BROKERAGES BULLISH ON NATGAS EXPANSIONBarcl...
Reuters
Thu, Jan 22
Abbott falls after Q4 revenue misses estimates
Shares of medical device maker Abbott Laboratories ABT.N fall 7% to $112.54 premarketCo posts Q4 revenue of $11.46 billion, missing analysts' estimate of $11.8 billion, according to data compiled by LSEGForecasts 2026 adj. profit in the range of $5.55 to $5.80 per share, compared with analysts...
Reuters
Thu, Jan 22
3 Millionaire-Maker Technology Stocks Worth a Closer Look
Key PointsIonQ could become one of the biggest winners in quantum computing.UiPath has a huge opportunity in the agentic AI field. GitLab looks misunderstood. 10 stocks we like better than IonQ › If you're looking for some potential millionaire-making stocks to invest in, you can just settle for ave...
The Motley Fool
Thu, Jan 22
Surf Air Mobility up on Mokulele Airlines investment
Shares of electric aircraft charter company Surf Air Mobility SRFM.N rise 4.5% to $2.5 premarket Co says will invest $22.4 million by the end of 2026 into Mokulele Airlines operationsInvestment to maintain service reliability, improve customer experience and optimize the network for the deployment o...
Reuters
Thu, Jan 22
Axogen slides on surgical device maker's $124 mln stock sale
Shares of surgical device maker Axogen AXGN.O down 7.2% at $30.62 premarket after $124 mln overnight follow-on priced Florida-based firm late Weds announced 4 mln shares at $31 Offering size increased from $85 mln, and priced at 6.1% discount to stock's last sale It intends to use...
Reuters
Thu, Jan 22
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
Jan 22 (Reuters) - Janux Therapeutics JANX.O said on Thursday it has entered a collaboration with Bristol Myers Squibb BMY.N to develop a new cancer treatment, sending its shares up more than 12% in premarket trading.The therapy is intended to treat "solid tumors" - meaning cancers that form...
Reuters
Thu, Jan 22
US STOCKS-Wall St futures rise further on Greenland relief; data in focus
Futures up: Dow 0.25%, S&P 500 0.47%, Nasdaq 0.75%McCormick forecasts weak annual profit on tariffsProcter & Gamble Q2 revenue is a touch shy of estimatesNovember PCE figures due at 10:00 a.m ETBy Sruthi Shankar and Pranav Kashyap Jan 22 (Reuters) - U.S. stock index futures climbed on...
Reuters
Thu, Jan 22
Janux shares rise on global cancer drug deal with Bristol Myers
Shares of drug developer Janux Therapeutics JANX.O rise 17.33% to $15.57 premarket Co says it signed a global licensing deal with Bristol Myers BMY.N to develop a new solid-tumor cancer drug Co says it may receive up to $50 mln upfront and near-term milestones, plus as much as $800 mln more tied to ...
Reuters
Thu, Jan 22
2 Cheap Tech Stocks to Buy Right Now
Key PointsDuolingo has nearly 130 million monthly active users but trades at just 20 times free cash flow.Kyndryl's hyperscaler revenue doubled year over year while margins expanded to 17.2%, and the stock is dirt cheap.Neither company is broken; both are out of favor and trading at bargain valuatio...
The Motley Fool
Thu, Jan 22
McCormick down after forecasting annual profit below expectations
Shares of Cholula sauce maker McCormick MKC.N down 5.5% at $62.90 premarketCo forecasts annual profit below expectations and reports Q4 profit miss due to impact from tariffs and higher input costsSees annual adjusted EPS between $3.05 to $3.13 vs. analysts' estimates of $3.22 - data compiled by...
Reuters
Thu, Jan 22
Datadog gains; Stifel raises to 'buy'
Cloud security firm Datadog's DDOG.O shares rise 3.1% to $127.27 premarketStifel upgrades stock to "buy" from "hold"Cuts PT to $160 from $205, still implying an upside of 29.6% to stock's last closeAverage rating of 43 analysts is "buy," their median PT is $204.35 - d...
Reuters
Thu, Jan 22
Is JPMorgan Chase Stock a Millionaire-Maker?
Key PointsJPMorgan Chase reported Q4 financial results that beat Wall Street estimates. A cost advantage and switching costs support the company’s economic moat. Shares trade at a steep price-to-book ratio.10 stocks we like better than JPMorgan Chase › With $4.4 trillion in assets (as of Dec. 31), J...
The Motley Fool
Thu, Jan 22
1
...
229
230
231
231
/
300
232
233
...
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free